Northern Trust Corp Inozyme Pharma, Inc. Transaction History

Northern Trust Corp

$709 Billion
Q2 2025

A detailed history of Northern Trust Corp transactions in Inozyme Pharma, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 139,074 shares of INZY stock, worth $556,296. This represents 0.0% of its overall portfolio holdings.

Number of Shares

139,074

Previous 428,124 67.52%

Holding current value

$556,296

Previous $389,000 42.93%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$0.82 - $4.0 $237,021 - $1.16 Million	-289,050 Reduced 67.52%	139,074 $556,000
Q1 2025 May 13, 2025	SELL	$0.91 - $3.07 $20,602 - $69,504	-22,640 Reduced 5.02%	428,124 $389,000
Q4 2024 Feb 14, 2025	BUY	$2.48 - $5.54 $29,559 - $66,031	11,919 Added 2.72%	450,764 $1.25 Million
Q3 2024 Nov 13, 2024	BUY	$4.31 - $6.0 $118,391 - $164,814	27,469 Added 6.68%	438,845 $2.3 Million
Q2 2024 Aug 14, 2024	SELL	$4.33 - $7.31 $36,817 - $62,156	-8,503 Reduced 2.03%	411,376 $1.83 Million
Q1 2024 May 14, 2024	SELL	$4.14 - $7.66 $19,987 - $36,982	-4,828 Reduced 1.14%	419,879 $3.22 Million
Q4 2023 Feb 13, 2024	BUY	$2.71 - $4.5 $244,062 - $405,270	90,060 Added 26.91%	424,707 $1.81 Million
Q3 2023 Nov 13, 2023	BUY	$4.09 - $7.0 $140,139 - $239,848	34,264 Added 11.41%	334,647 $1.41 Million
Q2 2023 Aug 11, 2023	BUY	$4.93 - $6.74 $1.25 Million - $1.72 Million	254,501 Added 554.69%	300,383 $1.67 Million
Q1 2023 May 15, 2023	SELL	$1.3 - $5.73 $79 - $349	-61 Reduced 0.13%	45,882 $262,000
Q4 2022 Feb 13, 2023	BUY	$1.05 - $2.82 $5,920 - $15,901	5,639 Added 13.99%	45,943 $48,000
Q3 2022 Nov 14, 2022	SELL	$2.57 - $5.45 $17,183 - $36,438	-6,686 Reduced 14.23%	40,304 $108,000
Q2 2022 Aug 12, 2022	SELL	$3.2 - $5.96 $213,865 - $398,324	-66,833 Reduced 58.72%	46,990 $224,000
Q1 2022 May 13, 2022	SELL	$3.87 - $7.55 $26,853 - $52,389	-6,939 Reduced 5.75%	113,823 $466,000
Q4 2021 Feb 08, 2022	BUY	$5.58 - $11.5 $26,008 - $53,601	4,661 Added 4.01%	120,762 $823,000
Q3 2021 Nov 15, 2021	SELL	$11.12 - $19.4 $51,619 - $90,054	-4,642 Reduced 3.84%	116,101 $1.35 Million
Q2 2021 Aug 13, 2021	BUY	$15.19 - $21.2 $80,112 - $111,808	5,274 Added 4.57%	120,743 $2.06 Million
Q1 2021 May 12, 2021	BUY	$17.77 - $27.9 $402,721 - $632,297	22,663 Added 24.42%	115,469 $2.29 Million
Q4 2020 Feb 11, 2021	BUY	$19.95 - $27.55 $837 - $1,157	42 Added 0.05%	92,806 $1.92 Million
Q3 2020 Nov 16, 2020	BUY	$17.54 - $30.2 $1.63 Million - $2.8 Million	92,764 New	92,764 $2.44 Million

Others Institutions Holding INZY

# of Institutions

Shares Held

51.5M

Call Options Held

162K

Put Options Held

View Full List

About Inozyme Pharma, Inc.

Ticker INZY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,145,700
Market Cap $161M
Description
Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...

More about INZY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Inozyme Pharma, Inc. Transaction History